|1|Pancreatic intraglandular metastasis predicts poorer outcome in postoperative patients with pancreatic ductal carcinoma. (23648465)
Oguro S.... Hiraoka N.
|2|Preoperative platelet-lymphocyte ratio in resected pancreatic ductal carcinoma: is it meaningful? (20579970)
DomA-nguez I.... FernA!ndez-del Castillo C.
|3|Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissue. (22892044)
Takadate T.... Unno M.
|4|Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model. (22190076)
Siddique H.R.... Saleem M.
|5|Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma. (21841817)
Eppinga R.D.... McNiven M.A.
|6|Clinicopathologic assessment of pancreatic ductal carcinoma located at the head of the pancreas, in relation to embryonic development. (22228049)
Okamura Y.... Nakao A.
|7|Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with I^-catenin in tumor progression. (21466814)
Xu H.... Kokudo N.
|8|Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1. (21272935)
Wang J.G.... Wang P.
|9|Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma. (20730891)
Jarboe E.A.... Layfield L.J.
|10|KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. (21224073)
Zammarchi F.... Mazzanti C.M.
|11|Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology. (19856421)
Han L.... Feng J.
|12|Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma. (18505086)
Pryczynicz A.... Czyzewska J.
|13|Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma. (19020717)
Inami K.... Hino O.
|14|Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy. (17072983)
Yekebas E.F.... Izbicki J.R.
|15|Pancreatic ductal carcinoma: from the bench to the bedside. (16998251)
|16|Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma. (15985168)
Attri J.... Wig J.
|17|Factors predicting recurrence after resection of pancreatic ductal carcinoma. (15968250)
Shibata K.... Kitano S.
|18|Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. (15951559)
Kobayashi A.... Saisho H.
|19|Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. (16335935)
Cecconi D.... Righetti P.G.
|20|Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. (16053509)
Ishikawa M.... Mano H.
|21|Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. (14973050)
MA1erkAPster S.... SchAofer H.
|22|A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. (15258755)
Monti P.... Piemonti L.
|23|Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. (15084983)
Ohshima T.... Saisho H.
|24|Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. (15548371)
GrA1tzmann R.... Saeger H.D.
|25|A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. (12692724)
Sipos B.... KlAPppel G.
|26|Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. (12717266)
Kuwahara K.... Chayama K.
|27|Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. (12650514)
Yamazaki K.... Ishida Y.
|28|Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma. (12824920)
Yoshida K.... Mano H.
|29|MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. (14681945)
Chhieng D.C.... Manne U.
|30|Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine. (14679576)
Cecconi D.... Righetti P.G.
|31|Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. (12448000)
Sipos B.... KlAPppel G.
|32|The molecular genetics of pancreatic ductal carcinoma. (12370658)
|33|Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma. (12429967)
Tobita K.... Makuuchi H.
|34|Endocrine and intermediate cells in pancreatic ductal carcinoma and in chronic pancreatitis. (12533945)
Szynaka B.... Szynaka P.
|35|Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. (11238189)
Weddle D.L.... Schuller H.M.
|36|Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives. (11391857)
Minari Y.... Dong M.
|37|A case of small pancreatic ductal carcinoma accompanied by intraductal mucin-producing pancreatic tumors. (10824701)
Yasoshima T.... Hirayama M.
|38|Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation. (9477096)
Matsubayashi H.... Saito T.
|39|Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival. (10076772)
Sessa F.... Capella C.
|40|Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. (9417916)
Biunno I.... Sgaramella V.
|41|p53 protein overexpression and K-ras codon 12 mutation in pancreatic ductal carcinoma: correlation with histologic factors. (9293533)
Kasuya K.... Koyanagi Y.
|42|Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. (9815776)
Suehara N.... Tanaka M.
|43|Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms. (8915489)
Franz M.G.... Gower W.R.
|44|Hematogenous metastases of pancreatic ductal carcinoma. (8532650)
Kamisawa T.... Okamoto A.
|45|Comparison between a newly established pancreatic cystadenocarcinoma cell-line, ocup-1 and cells derived from pancreatic ductal carcinoma. (21567058)
Chung Y.... Sowa M.
|46|Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. (8020665)
Bockman D.E.... Beger H.G.
|47|Sustained recovery from a solid type pancreatic ductal carcinoma originating in the pancreas tail: a case report. (8385066)
Furuta K.... Watanabe H.
|48|Branch duct origin of solid type pancreatic ductal carcinoma. (8481143)
Furuta K.... Miyazaki R.
|49|Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. (2539915)
Egami H.... Pour P.M.
|50|Dilemma of pancreatic ductal carcinoma. (453140)
Weingarten L.... Fischer M.G.